EP 0539803 A1 19930505 - Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses.
Title (en)
Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses.
Title (de)
Triazaspirodecanon-Methyl-Chromane zur Bekämpfung von Erkrankungen des Zentralnervensystems.
Title (fr)
Triazaspirodecanone-méthyl-chromanes pour le traitement des maladies du système nerveux central.
Publication
Application
Priority
DE 4135473 A 19911028
Abstract (en)
Triazaspirodecanonemethylchromans of the general formula (I) are prepared by reacting methylchromans, which are substituted on the methyl group by appropriate leaving groups, with triazaspirodecanones. The substances can be employed for the production of medicaments, in particular for medicaments for the control of central nervous system illnesses. <IMAGE>
Abstract (de)
Triazaspirodecanon-methylchromane der allgemeinen Formel (I) werden hergestellt, indem man Methylchromane, die an der Methylgruppe durch entsprechende Abgangsgruppen substituiert sind mit Triazaspirodecanonen umsetzt. Die Stoffe können zur Herstellung von Arzneimitteln eingesetzt werden, insbesondere für Arzneimittel zur Bekämpfung von Erkrankungen des Zentralnervensystems. <IMAGE>
IPC 1-7
IPC 8 full level
A61K 31/35 (2006.01); A61K 31/352 (2006.01); A61K 31/435 (2006.01); A61K 31/438 (2006.01); A61K 31/445 (2006.01); A61P 25/18 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 43/00 (2006.01); C07D 311/58 (2006.01); C07D 311/64 (2006.01); C07D 471/10 (2006.01); C07D 519/00 (2006.01)
CPC (source: EP KR US)
A61P 25/00 (2018.01 - EP); A61P 25/18 (2018.01 - EP); A61P 25/20 (2018.01 - EP); A61P 25/22 (2018.01 - EP); A61P 25/24 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 471/10 (2013.01 - EP KR US)
Citation (search report)
- [YD] US 3845060 A 19741029 - HUEBNER C
- [Y] EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.CHIMICA THERAPEUTICA. Bd. 9, Nr. 2, März 1974, CHATENAY-MALABRY FR Seiten 128 - 132 J. MAILLARD ET AL. 'Composés cycloalcanespiro-hétérocycliques XI. Nouveaux oxo-2 oxa-1 diaza-3,8 spiro(4,5)décanes substitués en 8, doués de propriétés adrénolytiques'
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
EP 0539803 A1 19930505; EP 0539803 B1 19990107; AT E175414 T1 19990115; AU 2626592 A 19930429; AU 650792 B2 19940630; CA 2081256 A1 19930429; CZ 322492 A3 19930714; DE 4135473 A1 19930429; DE 59209607 D1 19990218; DK 0539803 T3 19990830; ES 2125879 T3 19990316; FI 924848 A0 19921026; FI 924848 A 19930429; GR 3029450 T3 19990528; HU 9203382 D0 19930128; HU T64068 A 19931129; IL 103546 A0 19930315; JP 3257708 B2 20020218; JP H05222040 A 19930831; KR 930007945 A 19930520; MX 9205869 A 19930401; NO 923974 D0 19921013; NO 923974 L 19930429; TW 208010 B 19930621; US 6060482 A 20000509; ZA 928290 B 19930504
DOCDB simple family (application)
EP 92117606 A 19921015; AT 92117606 T 19921015; AU 2626592 A 19921007; CA 2081256 A 19921023; CS 322492 A 19921026; DE 4135473 A 19911028; DE 59209607 T 19921015; DK 92117606 T 19921015; ES 92117606 T 19921015; FI 924848 A 19921026; GR 990400535 T 19990219; HU 9203382 A 19921028; IL 10354692 A 19921026; JP 31279892 A 19921028; KR 920019792 A 19921027; MX 9205869 A 19921013; NO 923974 A 19921013; TW 81107641 A 19920926; US 96316592 A 19921019; ZA 928290 A 19921027